The use of an intravenous fish oil emulsion enriched with omega-3 fatty acids in patients with cystic fibrosis

Nutrition

Volumn 12, Issue 5, 1996, Pages 334-339

  Katz, David P ^a,b,c,d   Manner, Tuula ^a,b,c   Furst, Peter ^a,b,c   Askanazi, Jeffrey ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HOHENHEIM   (Germany)

^d MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

cystic fibrosis; fish oils; intravenous lipid emulsions

Indexed keywords

FISH OIL; LIPOSYN; LIPOSYN III; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGAVENOUS; UNCLASSIFIED DRUG;

ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG BIOAVAILABILITY; DRUG SAFETY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030152011     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(96)80056-6     Document Type: Article

References (38)

1. 1. Katz DP, Schwartz S, Askanazi J. Therapeutic value of omega-3 fatty acids derived from fish oil: Biochemical and cellular basis. Nutrition 1993;9:113
2. 2. Gorlin R. The biological actions and potential clinical significance of dietary ω-3 fatty acids. Arch Inter Med 1988;148:2043
3. 3. Samuelsson B, Dahlen S-E, Lindgren JA, et al. Leukotrienes and lipoxins. Structures, biosynthesis, and biological effects. Science 1987;237:1171
4. 4. Voelkel NF, Stenmark KR, Westcott JY, et al. Lung eicosanoid metabolism. Clin Chest Med 1989;10:95
5. 5. Manner T, Katz DP, Skeie B, et al. Fish oils and the lung. Clin Nutr 1993;12:131
6. 6. Archer SL, Johnson GJ, Gebhard RL, et al. Effect of dietary fish oil on lung profile and hypoxic pulmonary hypertension. J Appl Physiol 1989;66:1662
7. 7. Campbell IM, Crazier DN, Caton RB. Abnormal fatty acid composition and impaired oxygen supply in cystic fibrosis. Pediatrics 1976;57:480
8. 8. Rosenlund ML, Kim HK, Kritchevsky D. Essential fatty acids in cystic fibrosis. Nature 1974;251:719
9. 9. Hubbard VS, Dunn DG, di Sant'Agnese PA. Abnormal fatty acid composition of plasma lipids in cystic fibrosis: a primary or secondary defect? Lancet 1977;2:1302
10. 10. Knapp HR, Reilly IA, Alessandrini P, et al. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986;314:937
11. 11. Dry J, Vincent D. Effect of a fish oil diet in asthma: Results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991; 95:156
12. 12. Pomposelli JJ, Flores EA, Blackburn GL, et al. Diets enriched with n-3 fatty acids ameliorate lactic acidosis by improving endotoxin-induced tissue hypoperfusion in guinea pigs. Ann Surg 1991;213:166
13. 13. Nakamura MT, Tang AB, Villanueva J, et al. Reduced tissue arachidonic acid concentration with ethanol feeding in miniature pigs. Am J Clin Nutr 1992;56:467
14. 3. Biochem Biophys Res Comm 1988;151:1386
15. 15. Mashima Y, Tashiro T, Yamamori H, et al. Effect of intravenous fish-soybean-oil emulsion on serum fatty acid composition in total parenteral nutrition. Proceedings of the 16th Meeting of the American Society of Parenteral and Enteral Nutrition, 1992:475 (abstract 61)
16. 16. Elmadfa I, Stroh S, Brandt K, et al. Influence of a single parenteral application of a 10% fish oil emulsion on plasma fatty acid pattern and the function of thrombocytes in young adult men. Ann Nutri Metab 1993;37:8
17. 17. Ikehata A, Hiwatashi N, Kinouchi Y, et al. Effect of intravenously infused eicosapentaenoic acid on the leukotriene generation in patients with active Crohn's disease. Am J Clin Nutr 1992;56:938
18. 18. Bruckner GG, Lokesh B, German B, et al. Biosynthesis of prostanoids, tissue fatty acid composition and thrombotic parameters in rats fed diets enriched with docosahexaenoic and eicosapentaenoic acids. Thromb Res 1984;34:479
19. 19. Archer SL, Nelson D, Gebhard R, et al. Effects of dietary fish oil on lung phospholipid fatty acid composition and intrinsic pulmonary vascular reactivity. Cardiovasc Res 1987;21:928
20. 20. Carelstedt-Duke J, Brönnegård M, Strandvik B. Pathological regulation of arachidonic release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci 1986;83:9202
21. 2) metabolism? J Pediatr Gastroenterol Nutr 1984;3:15
22. 22. Goldstein W, Döring G. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis 1986;134:49
23. 23. Kharazmi A, Rechnitzer C, Schiotz PO, et al. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aerigunosa infection. Eur Clin Invest 1987; 17:256
24. 24. Voelkel NF, Stenmark KR, Westcott JY, Chang SW. Lung eicosanoid metabolism. Clin Chest Med 1989;10:95
25. 25. Maron Z, Shelhamer JH, Kaliner M. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J Clin Invest 1981;67:1695
26. 26. Kadowitz PJ, Spannhake EW, Lewin JL, Hyman AL. Differential effects of prostaglandins on the pulmonary vascular bed. Adv Prostaglandin Thromboxane Res 1980;7:731
27. 27. Craig-Schmidt MC, Faircloth SA, Teer PA, Weete JD, Wu CY. The essential fatty acid deficient chicken as a model for cystic fibrosis. Am J Clin Nutr 1986;44:816
28. 28. Harper TB, Chase HP, Henson J, Henson PM: Essential fatty acid deficiency in the rabbit as a model of nutritional impairment in cystic fibrosis. In vitro and in vivo effects on lung defense mechanisms. Am Rev Respir Dis 1982;126:540
29. 29. Elliot RB. A therapeutical trial of fatty acid supplementation in cystic fibrosis. Pediatrics 1976;57:474
30. 30. Kusoffsky E, Strandvik B, Troell S. Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983;2:434
31. 31. Askanazi J, Rothkopf M, Rosenbaum SH, et al. Treatment of cystic fibrosis with long term home parenteral nutrition. Nutr Int 1987; 3:277
32. 32. Skeie B, Askanazi J, Rothkopf M, et al. Improved exercise tolerance with long-term parenteral nutrition in cystic fibrosis. Crit Care Med 1997;15:960
33. 33. Kirvela O, Stern R, Askanazi J, et al. Effects of long term parenteral nutrition in cystic fibrosis: a controlled clinical trial. Nutrition 1993;9:119
34. 34. Lockette WE, Webb RC, Culp BR, Pitt B. Vascular reactivity and high dietary eicosapentaenoic acid. Prostaglandins 1982;24:631
35. 35. Martinet Y, Rom WN, Grotendorst GR, et al. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987;317:202
36. 36. Fox PL, DiCorleto PE. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 1988; 241:453
37. 37. Sarris GE, Fann JI, Sokoloff MH, et al. Mechanisms responsible for inhibition of vein-graft arteriosclerosis by fish oil. Circulation 1989;80:1109
38. 38. Lehr HA, Hübner C, Nolte D, Kohlschütter A, Messmer K. Dietary fish oil blocks the microcirculatory manifestations of ischemiareperfusion injury in striated muscle in hamsters. Proc Natl Acad Sci USA 1991;88:6726